Mark Williams
President chez MARVEL BIOSCIENCES CORP.
Fortune : 543 679 $ au 31/03/2024
Profil
Mark Williams is the founder of Sanomune, Inc. He currently holds two positions as Director at Algernon Pharmaceuticals, Inc. and President, Director & Chief Science Officer at Marvel Biosciences Corp.
Previously, he was Director & Chief Science Officer at First Responder Technologies, Inc. from 2019 to 2020, Vice President-Research at DiaMedica Therapeutics, Inc. from 2005 to 2016, Vice President-Research at Cerebra Health, Inc. from 2016 to 2018, and Chief Scientific Officer at Alphanco Venture Corp.
He holds a doctorate from the University of Alberta and an MBA from the University of Manitoba.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
MARVEL BIOSCIENCES CORP
12,57% | 04/12/2023 | 5 000 049 ( 12,57% ) | 540 005 $ | 31/03/2024 |
30/01/2024 | 44 800 ( 0,22% ) | 3 674 $ | 31/03/2024 |
Postes actifs de Mark Williams
Sociétés | Poste | Début |
---|---|---|
MARVEL BIOSCIENCES CORP. | President | 14/06/2021 |
ALGERNON PHARMACEUTICALS INC. | Director/Board Member | 22/09/2021 |
Anciens postes connus de Mark Williams
Sociétés | Poste | Fin |
---|---|---|
QUEBEC PEGMATITE HOLDINGS CORP. | Chief Tech/Sci/R&D Officer | 30/09/2020 |
Cerebra Health, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 28/11/2016 |
ALPHANCO VEN | Chief Tech/Sci/R&D Officer | - |
Sanomune, Inc.
Sanomune, Inc. Pharmaceuticals: MajorHealth Technology Sanomune, Inc. manufactures and distributes biopharmaceutical products. The company was founded by Mark Williams in 1999 and is headquartered in Winnipeg, Canada. | Founder | - |
Formation de Mark Williams
University of Alberta | Doctorate Degree |
University of Manitoba | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
DIAMEDICA THERAPEUTICS INC. | Health Technology |
ALGERNON PHARMACEUTICALS INC. | Health Technology |
MARVEL BIOSCIENCES CORP. | Health Technology |
Entreprise privées | 4 |
---|---|
Sanomune, Inc.
Sanomune, Inc. Pharmaceuticals: MajorHealth Technology Sanomune, Inc. manufactures and distributes biopharmaceutical products. The company was founded by Mark Williams in 1999 and is headquartered in Winnipeg, Canada. | Health Technology |
Cerebra Health, Inc. | |
First Responder Technologies, Inc.
First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
Alphanco Venture Corp.
Alphanco Venture Corp. Financial ConglomeratesFinance Alphanco Venture Corp. engages in the identification, evaluation and negotiation of agreement to acquire an interest in a material asset or business. The company was founded by Joanne Yan on August 1, 2018 and is headquartered in West Vancouver, Canada. | Finance |